Statins Promote Cardiac Infarct Healing by Modulating Endothelial Barrier Function Revealed by Contrast-Enhanced Magnetic Resonance Imaging. Issue 1 (January 2018)
- Record Type:
- Journal Article
- Title:
- Statins Promote Cardiac Infarct Healing by Modulating Endothelial Barrier Function Revealed by Contrast-Enhanced Magnetic Resonance Imaging. Issue 1 (January 2018)
- Main Title:
- Statins Promote Cardiac Infarct Healing by Modulating Endothelial Barrier Function Revealed by Contrast-Enhanced Magnetic Resonance Imaging
- Authors:
- Leenders, Geert J.
Smeets, Mirjam B.
van den Boomen, Maaike
Berben, Monique
Nabben, Miranda
van Strijp, Dianne
Strijkers, Gustav J.
Prompers, Jeanine J.
Arslan, Fatih
Nicolay, Klaas
Vandoorne, Katrien - Abstract:
- Abstract : Objective—: The endothelium has a crucial role in wound healing, acting as a barrier to control transit of leukocytes. Endothelial barrier function is impaired in atherosclerosis preceding myocardial infarction (MI). Besides lowering lipids, statins modulate endothelial function. Here, we noninvasively tested whether statins affect permeability at the inflammatory (day 3) and the reparative (day 7) phase of infarct healing post-MI using contrast-enhanced cardiac magnetic resonance imaging (MRI). Approach and Results—: Noninvasive permeability mapping by MRI after MI in C57BL/6, atherosclerotic ApoE −/−, and statin-treated ApoE −/− mice was correlated to subsequent left ventricular outcome by structural and functional cardiac MRI. Ex vivo histology, flow cytometry, and quantitative polymerase chain reaction were performed on infarct regions. Increased vascular permeability at ApoE −/− infarcts was observed compared with C57BL/6 infarcts, predicting enhanced left ventricular dilation at day 21 post-MI by MRI volumetry. Statin treatment improved vascular barrier function at ApoE −/− infarcts, indicated by reduced permeability. The infarcted tissue of ApoE −/− mice 3 days post-MI displayed an unbalanced Vegfa (vascular endothelial growth factor A)/ Angpt1 (angiopoetin-1) expression ratio (explaining leakage-prone vessels), associated with higher amounts of CD45 + leukocytes and inflammatory LY6C hi monocytes. Statins reversed the unbalanced Vegfa/Angpt1 expression,Abstract : Objective—: The endothelium has a crucial role in wound healing, acting as a barrier to control transit of leukocytes. Endothelial barrier function is impaired in atherosclerosis preceding myocardial infarction (MI). Besides lowering lipids, statins modulate endothelial function. Here, we noninvasively tested whether statins affect permeability at the inflammatory (day 3) and the reparative (day 7) phase of infarct healing post-MI using contrast-enhanced cardiac magnetic resonance imaging (MRI). Approach and Results—: Noninvasive permeability mapping by MRI after MI in C57BL/6, atherosclerotic ApoE −/−, and statin-treated ApoE −/− mice was correlated to subsequent left ventricular outcome by structural and functional cardiac MRI. Ex vivo histology, flow cytometry, and quantitative polymerase chain reaction were performed on infarct regions. Increased vascular permeability at ApoE −/− infarcts was observed compared with C57BL/6 infarcts, predicting enhanced left ventricular dilation at day 21 post-MI by MRI volumetry. Statin treatment improved vascular barrier function at ApoE −/− infarcts, indicated by reduced permeability. The infarcted tissue of ApoE −/− mice 3 days post-MI displayed an unbalanced Vegfa (vascular endothelial growth factor A)/ Angpt1 (angiopoetin-1) expression ratio (explaining leakage-prone vessels), associated with higher amounts of CD45 + leukocytes and inflammatory LY6C hi monocytes. Statins reversed the unbalanced Vegfa/Angpt1 expression, normalizing endothelial barrier function at the infarct and blocking the augmented recruitment of inflammatory leukocytes in statin-treated ApoE −/− mice. Conclusions—: Statins lowered permeability and reduced the transit of unfavorable inflammatory leukocytes into the infarcted tissue, consequently improving left ventricular outcome. Abstract : Supplemental Digital Content is available in the text. … (more)
- Is Part Of:
- Arteriosclerosis, thrombosis, and vascular biology. Volume 38:Issue 1(2018)
- Journal:
- Arteriosclerosis, thrombosis, and vascular biology
- Issue:
- Volume 38:Issue 1(2018)
- Issue Display:
- Volume 38, Issue 1 (2018)
- Year:
- 2018
- Volume:
- 38
- Issue:
- 1
- Issue Sort Value:
- 2018-0038-0001-0000
- Page Start:
- Page End:
- Publication Date:
- 2018-01
- Subjects:
- atherosclerosis -- hydroxymethylglutaryl-CoA reductase inhibitors -- magnetic resonance imaging -- myocardial infarction -- permeability
Arteriosclerosis -- Periodicals
Thrombosis -- Periodicals
Blood-vessels -- Pathophysiology -- Periodicals
Electronic journals
616.13 - Journal URLs:
- http://atvb.ahajournals.org/contents-by-date.0.shtml ↗
http://journals.lww.com ↗ - DOI:
- 10.1161/ATVBAHA.117.310339 ↗
- Languages:
- English
- ISSNs:
- 1079-5642
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 1733.670000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 8888.xml